Researchers investigated whether spontaneous intracerebral hemorrhages among blood donors after blood donation were linked to the development of spontaneous ICH among transfusion recipients.
Despite failing its PhII test, Xenon sees future for major depression drug
Xenon Pharmaceuticals’ major depressive disorder drug candidate didn’t reach statistical significance versus placebo in the primary endpoint of a mid-stage trial, but the Canadian biotech
November 28, 2023